Tatar, C. Et Al. 2023. Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 CD133+/CD44+ cells. Biochemical and Biophysical Research Communications , vol.680 , 194-210.

Tatar, C., BİRAY AVCI, Ç., Açıkgöz, E., & Oktem, G., (2023). Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 CD133+/CD44+ cells. Biochemical and Biophysical Research Communications , vol.680, 194-210.

Tatar, Cansu Et Al. "Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 CD133+/CD44+ cells," Biochemical and Biophysical Research Communications , vol.680, 194-210, 2023

Tatar, Cansu Et Al. "Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 CD133+/CD44+ cells." Biochemical and Biophysical Research Communications , vol.680, pp.194-210, 2023

Tatar, C. Et Al. (2023) . "Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 CD133+/CD44+ cells." Biochemical and Biophysical Research Communications , vol.680, pp.194-210.

@article{article, author={Cansu Tatar Et Al. }, title={Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 CD133+/CD44+ cells}, journal={Biochemical and Biophysical Research Communications}, year=2023, pages={194-210} }